Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 169(6): 795-797, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33098506

RESUMO

The effects of TLR4 blocker on blood cell morphology, concentrations proinflammatory cytokines, and functional state of the liver and kidneys were studied in outbred male rats (n=60) after intravenous injection of 20 mg/kg LPS isolated from opportunistic Proteus mirabilis strain ATCC 51393. TLR4 blocker TLR4-IN-C34 was injected intravenously in a dose of 1 mg/kg/day over 3 days. Systemic inflammatory reaction induced by LPS was characterized by elevation of serum TNFα, IL-1ß, IL-6, erythrocyte sedimentation rate, leukocytosis, and thrombocytosis. Increased activity of hepatocyte enzymes (ALT, alkaline phosphatase, and lactate dehydrogenase), retention of nitrogen metabolites (urea and creatinine), elevated content of protein oxidation products, and enhanced protein catabolism were also observed. Administration of TLR4 blocker reduced parameters of inflammatory reaction and prevented the development of hypercatabolic syndrome; endotoxicosis and kidney function indicators approached the normal levels.


Assuntos
Anti-Inflamatórios/farmacologia , Leucocitose/tratamento farmacológico , Lipopolissacarídeos/antagonistas & inibidores , Piranos/farmacologia , Sepse/tratamento farmacológico , Trombocitose/tratamento farmacológico , Receptor 4 Toll-Like/antagonistas & inibidores , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Animais , Animais não Endogâmicos , Creatinina/sangue , Modelos Animais de Doenças , Regulação da Expressão Gênica , Injeções Intravenosas , Interleucina-1beta/sangue , Interleucina-1beta/genética , Interleucina-6/sangue , Interleucina-6/genética , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , L-Lactato Desidrogenase/sangue , Leucocitose/sangue , Leucocitose/patologia , Lipopolissacarídeos/toxicidade , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Masculino , Proteus mirabilis/química , Ratos , Sepse/sangue , Sepse/patologia , Transdução de Sinais , Trombocitose/sangue , Trombocitose/patologia , Receptor 4 Toll-Like/sangue , Receptor 4 Toll-Like/genética , Fator de Necrose Tumoral alfa/sangue , Fator de Necrose Tumoral alfa/genética , Ureia/sangue
2.
Eksp Klin Farmakol ; 74(2): 44-6, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21476286
3.
Eksp Klin Farmakol ; 73(11): 41-3, 2010 Nov.
Artigo em Russo | MEDLINE | ID: mdl-21254599

RESUMO

Preclinical safety of reamberin, a preparation of succinic acid intended for the treatment of patients with shock conditions of different etiology, and remaxol a drug intended for the treatment of patients with liver dysfunction caused by acute intoxication was performed. Both medicines belong to the 5th class of practically non-toxic drugs. Their administration to experimental animals for 30 days did not cause toxic effects on the functional and morphological state of main systems and organs. Both medicines do not affect specific (humoral and cellular) and non-specific immune response and do not cause sensibilization, mutagenic, embryotoxic and teratogenic effects, and also do no alter parameters of reproductive functions of rats.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Meglumina/análogos & derivados , Succinatos/efeitos adversos , Succinatos/farmacologia , Animais , Cães , Avaliação Pré-Clínica de Medicamentos , Feminino , Masculino , Meglumina/efeitos adversos , Meglumina/farmacologia , Ratos , Choque/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...